Elevai Labs (ELAB) Short Interest Ratio & Short Volume

Short interest is the volume of Elevai Labs shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 145,500 shares of ELAB short. Learn More on Elevai Labs' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELAB shares currently have a short interest ratio of 1.0. Learn More on Elevai Labs's short interest ratio.

Elevai Labs saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 145,500 shares, an increase of 73.6% from the previous total of 83,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Elevai Labs: Equillium, Inc. (1.61%), Eagle Pharmaceuticals, Inc. (9.97%), CASI Pharmaceuticals, Inc. (0.83%), Ocuphire Pharma, Inc. (5.09%), Kronos Bio, Inc. (1.67%), Aadi Bioscience, Inc. (5.54%), Clene Inc. (0.16%), Daré Bioscience, Inc. (0.53%), Gain Therapeutics, Inc. (0.60%), NextCure, Inc. (0.43%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling ELAB is an investing strategy that aims to generate trading profit from Elevai Labs as its price is falling. ELAB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Elevai Labs occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELAB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELAB, twice per month. The most recent reporting period available is May, 15 2024.